Pengfei Yu

Pengfei Yu

Auto-generated profile, based on publicly available information

Pengfei Yu

Department of Biomedical Sciences, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
ELEric S. Lightcap
Eric S. Lightcap
PYPengfei Yu
Pengfei Yu
SGStephen Grossman
Stephen Grossman
KSKeli Song
Keli Song
MKMithun Khattar
Mithun Khattar
DHDennis Huszar
Dennis Huszar
TAK-981, a first-in-class small-molecule SUMOylation inhibitor, activates type I interferon signaling to promote antitumor immune responses in mice.

30 May 2022 in Nature Cancer
Verified
Journal Article
Closed access
PDF file
HZHongru Zhang
Hongru Zhang
PYPengfei Yu
Pengfei Yu
VTVivek S. Tomar
Vivek S. Tomar
XCXiangjie Chen
Xiangjie Chen
MAMatthew J. Atherton
Matthew J. Atherton
SFSerge Fuchs
Serge Fuchs

4 November 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
ZLZhen Lu
Zhen Lu
JCJinyun Chen
Jinyun Chen
PYPengfei Yu
Pengfei Yu
MAMatthew J. Atherton
Matthew J. Atherton
JGJun Gui
Jun Gui
SFSerge Fuchs
Serge Fuchs
Activities of dendritic cells (DCs) that present tumor antigens are often suppressed in tumors. Here we report that this suppression is induced by tumor microenvironment-derived factors, which activate the activating transcription factor-3 (ATF3) transcription factor and downregulate cholesterol 25-hydroxylase (CH25H). Loss of CH25H in antigen presenting cells isolated from human lung tumors is associated with tumor growth and lung cancer progression. Accordingly, mice lacking CH25H in DCs exhibit an accelerated tumor growth, decreased infiltration and impaired activation of intratumoral CD8+ T cells. These mice do not establish measurable long-term immunity against malignant cells that undergo chemotherapy-induced immunogenic cell death. Mechanistically, downregulation of CH25H stimulates membrane fusion between endo-phagosomes and lysosomes, accelerates lysosomal degradation and restricts cross-presentation of tumor antigens in the intratumoral DCs. Administration of STING agonist MSA-2 reduces the lysosomal activity in DCs, restores antigen cross presentation, and increases therapeutic efficacy of PD-1 blockade against tumour challenge in a CH25H-dependent manner. These studies highlight the importance of downregulation of CH25H in DCs for tumor immune evasion and resistance to therapy.

15 November 2022 in Molecular Cancer Research
Verified
Journal Article
Closed access
PDF file
NMNoreen McBrearty
Noreen McBrearty
CCChristina Cho
Christina Cho
JCJinyun Chen
Jinyun Chen
FZFarima Zahedi
Farima Zahedi
APAmy R. Peck
Amy R. Peck
SFSerge Fuchs
Serge Fuchs
Cholesterol dependence is an essential characteristic of pancreatic ductal adenocarcinoma (PDAC). Cholesterol 25-hydroxylase (CH25H) catalyzes monooxygenation of cholesterol into 25-hydroxycholesterol, which is implicated in inhibiting cholesterol biosynthesis and in cholesterol depletion. Here, we show that, within PDAC cells, accumulation of cholesterol was facilitated by the loss of CH25H. Methylation of the CH25H gene and decreased levels of CH25H expression occurred in human pancreatic cancers and was associated with poor prognosis. Knockout of Ch25h in mice accelerated progression of Kras-driven pancreatic intraepithelial neoplasia. Conversely, restoration of CH25H expression in human and mouse PDAC cells decreased their viability under conditions of cholesterol deficit, and decelerated tumor growth in immune competent hosts. Mechanistically, the loss of CH25H promoted autophagy resulting in downregulation of MHC-I and decreased CD8+ T-cell tumor infiltration. Re-expression of CH25H in PDAC cells combined with immune checkpoint inhibitors notably inhibited tumor growth. We discuss additional benefits that PDAC cells might gain from inactivation of CH25H and the potential translational importance of these findings for therapeutic approaches to PDAC. Implications: Loss of CH25H by pancreatic cancer cells may stimulate tumor progression and interfere with immunotherapies.

20 August 2022 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Open access
YYYan-Qi Yang
Yan-Qi Yang
PGPan Ge
Pan Ge
MLMo-Qi Lv
Mo-Qi Lv
PYPeng-Fei Yu
Peng-Fei Yu
Zhigang LiuZhigang Liu
Zhigang Liu
DZdangxia zhou
dangxia zhou
Formaldehyde (FA) serves as a prevailing air pollutant, which has seriously threatened public health in recent years. Of all the known health effects, lung injury is one of the most severe risks. However, little is known about the circRNAs related molecular mechanism in the development of lung injury induced by FA. This study was designed to explore the potential roles of dysregulated circRNAs as well as its mechanism in FA-induced lung injury. In the present study, 24 male SD rats were exposed to formaldehyde (control, 0.5, 2.46 and 5 mg/m3) for 8 h per day for 8 weeks to induce lung injury. We used H&E staining to evaluate the histopathological changes of lung injury indifferent groups. The expression of circRNAs in lung tissue was detected by real-time PCR. Meanwhile, circRNA/miRNA/mRNA interaction networks were predicted by bioinformatics analysis. Our study revealed that formaldehyde exposure resulted in abnormal histopathological changes in lung tissues. Moreover, the expression of rno_circRNA_008646 was significantly higher in lung tissues of formaldehyde exposure rats than in control. Bioinformatics analysis showed that one potential target miRNA/mRNA for rno_circRNA_008646 was rno-miR-224/Forkhead Box I1 (FOXI1). Besides, luciferase report gene confirmed that there was targeted binding relationship between rno_circRNA_008646 and rno-miR-224, rno-miR-224 and FOXI1. Further verification experiments indicated that the expression of rno_circRNA_008646 was negatively correlated rno-miR-224, while it was positively correlated with FOXI1. JASPAR database showed transcription factor FOXI1 located in promotor of CF Transmembrane Conductance Regulator (CFTR). Both FOXI1 and CFTR were up-regulated in lung tissues after formaldehyde exposure. In conclusion, our findings suggested that formaldehyde may induce lung injury, and this may be caused by up-regulatedrno_circRNA_008646, which medicated rno-miR-224/FOXI1/CFTR axis.

4 December 2023 in Cancer Immunology Research
Verified
Journal Article
Closed access
PDF file
PYPengfei Yu
Pengfei Yu
SCShuwen Cao
Shuwen Cao
SYShyh-Ming Yang
Shyh-Ming Yang
BRBantukallu Ganesh Rai
Bantukallu Ganesh Rai
NMNatalia J. Martinez
Natalia J. Martinez
MHMalay Haldar
Malay Haldar
Globally, hepatocellular carcinoma (HCC) is one of the most commonly diagnosed cancers and a leading cause of cancer-related death. We previously identified an immune evasion pathway whereby tumor cells produce retinoic acid (RA) to promote differentiation of intratumoral monocytes into protumor macrophages. Retinaldehyde dehydrogenase 1 (RALDH1), RALDH2, and RALDH3 are the three isozymes that catalyze RA biosynthesis. In this study, we have identified RALDH1 as the key driver of RA production in HCC and demonstrated the efficacy of RALDH1-selective inhibitors (Raldh1-INH) in suppressing RA production by HCC cells. Raldh1-INH restrained tumor growth in multiple mouse models of HCC by reducing the number and tumor-supporting functions of intratumoral macrophages as well as increasing T-cell infiltration and activation within tumors. Raldh1-INH also displayed favorable pharmacokinetic, pharmacodynamic, and toxicity profiles in mice thereby establishing them as promising new drug candidates for HCC immunotherapy.